CClinicalTrials.gg
Status unknownNCT03800628Updated Jan 14, 2019

Resource Availability Following Critical Illness

An observational study in Quality of Life, sponsored by Walden University. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-01-14.

Sponsored by Walden University · Observational

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Other
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this qualitative study is to explore the vital issues in recovery of QOL from the perspective of survivors of critical illness and understand these patients' views on rehabilitative services in the United States (U.S.). The theoretical framework for this study is Max Weber's Rational Choice Theory (RCT). The research questions will focus on understanding post-ICU QOL and the patients' experience with rehabilitative services following critical illness. A phenomenological study design is being employed, using semi-structured individual interviews with critical illness survivors. Data from the interviews will be coded for thematic analysis. The implications for social change include defining the meaning of QOL for an ICU survivor and improving healthcare policies for the therapies necessary to return survivors to a life worth living.

Read the detailed description

The purpose of this qualitative study is to understand the patient perception of QOL after surviving critical illness and how survivors can help illuminate gaps in current health policies to provide better recovery resources for this growing population.

The central research questions are:

RQ1: What are the issues important to preserve quality of life from the perspective of critical illness survivors? RQ2: How do survivors of critical illness describe rehabilitative services after discharge?

02

Conditions studied

  • Quality of Life

Browse trials for

Keywords

  • survivor
  • QOL
  • resources
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's planned enrollment of 30 is below the median of 130 across 867 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Walden University is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

critical illness survivors

Inclusion criteria

  • critical illness survivors within 18 months of ICU discharge
  • minimum 48 hours of mechanical ventilation
  • ability to read and understand English
  • over the age of 18

Exclusion criteria

Exclusion Criteria:

  • emotional or psychological inability to participate in a 30-min interview
  • not meeting inclusion criteria
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
30 participants (estimated)
Patient registry
No

Interventions

  • Otherqualitative study

    semi-structured interviews

06

What researchers measure

Primary outcomes

  1. RQ1: What are the issues important to preserve quality of life from the perspective of critical illness survivors?

    semi-structured, open-ended qualitative interview

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03800628
Lead sponsor
Walden University
Collaborators
Wake Forest University Health Sciences
Responsible party
Michelle McMoon (Principle Investigator, Walden University) — Principal investigator
First posted
Jan 11, 2019
Start date
Dec 7, 2018
Primary completion
Jun 30, 2019 (estimated)
Completion
Aug 30, 2019 (estimated)
Last update
Jan 14, 2019

Study contacts

Michelle M McMoon
Contact
michelle.mcmoon@waldenu.edu
410-300-2786

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion